Skip to main content
. 2021 Oct 30;13(21):5459. doi: 10.3390/cancers13215459

Figure 3.

Figure 3

Chemical structure of (A) thymidine, 18F-FLT, and 18F-FMAU; (B) 18F-FLT PET imaging of a patient with grade II breast cancer 1 week after administration of combination chemotherapy. (a) pretreatment and (b) posttreatment of a patient with lobular breast cancer who responded to treatment. (c) pretreatment and (d) posttreatment of a patient with invasive ductal breast cancer who did not respond to treatment [104].